83PDPROGNOSIS OF STAGE III NON-SMALL-CELL LUNG CANCER PATIENTS PRESENTING WITH ISOLATED BRAIN FAILURE AFTER DEFINITIVE CONCURRENT CHEMORADIATION THERAPYdoi:10.1093/annonc/mdv049.03Topkan, E.Guler, O. C.Yildirim, B. A.Annals of Oncology
Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without con... inter- val in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent ...
Group 2 patients had a better prognosis than Group 1 patients (P = 0.0028) but there were no differences in prognosis between Groups 2 and 3 and between Groups 1 and 3. Of potential prognostic factors examined, female gender (P = 0.00012), age > or = 60 (P = 0.00000), KPS > or ...
Afatinib, an irreversible ErbB-family blocker, could improve the survival of advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer patients (NSCLCm+). This phase II trial (NCT04201756) aimed to assess the feasibility of neoadjuvant Afatinib treatment for stage III NSCLC...
But you're not a number. No one, including your doctor, can tell you exactly how long you'll live. Your outlook depends on a lot of things, including your age, health, where the cancer has spread, and the kind of treatment you get. ...
Pathologic stage Ⅰ non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen:Clinicopathologic characteristics and prognosis[J]... H Matsuguma,R Nakahara,S Igarashi,... - 《Journal of Thoracic & Cardiovascular Surgery》 被引量: 101发表: 2008年 Prognostic value of ...
Keywords: lung cancer prognosis; lung cancer stages; lung cancer stage classification; prognostic factors; TNM classification 学习笔记 1.首先从整个TNM分期委员会传递出来的信息是:TNM分期是一种肿瘤解剖学范围, 解剖学外仍然有很多因素(如patient-related...
Objective To evaluate and summarize the experiences of the treatment of the patients with stage Ⅲ non-small cell lung cancer(NSCLC). Methods We reviewed a total of 188 cases treated with different methods, which included preoperative and postoperative chemotherapy combination with operation, operation...
Clinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancersClinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancersdoi:10.1016/0169-5002(94)94477-6None...
Therefore, further classification beyond pT and pN staging and other pathological features influencing stage III CC outcomes remains of interest to refine risk classification and to guide adjuvant treatment.3,8,9 Tumor budding (Bd), defined as a single cancer cell of up to four cancer cells at ...